Center for Biotechnology

Research


The Khalifa University Center of Excellence in Biotechnology (BTC) was established on 2 June 2015 to develop the university’s capabilities in training and research to respond to three of the six priority areas under the four pillars of the UAE 2021 vision.  Without a local effort in genome research, the targets set and the vision to develop a knowledge economy in bioscience and competencies in laboratory diagnostic practice is highly problematic.  Since its foundation, BTC has developed competencies in genomics (Theme 1) and bioinformatics (Theme 2) in collaboration with a plethora of external stakeholders. 


The development of new therapeutic modalities or the use of existing pharmaceuticals in appropriate doses (pharmacogenomics).

The development of improved analysis methodology and pipelines for the identification of variants that cause disease.

The discovery of genetic markers that are relevant for diagnosis of disease and screening for predispositions in the Arabian population.

External Collaborators
  • Abu Dhabi Police General Head Quarters, Abu Dhabi
  • Al Ain Fertility Center, Al Ain
  • Dubai Health Authority, Dubai
  • Mafraq Hospital, Abu Dhabi
  • Ministry of Health and Prevention, Dubai
  • National Rehabilitation Center, Abu Dhabi
  • Newcastle University, United Kingdom
  • Sheikh Khalifa Medical City, Abu Dhabi
  • Tawam Hospital, Al Ain
  • University of Oxford, United Kingdom
  • University of Western Australia, Australia
  • Zayed University, Abu Dhabi

External Sponsors

  • Aljalila Foundation
  • Sandooq Alwatan